What is it about?
Once the data from a clinical trial are available for analysis it is common practice to carry out ‘tests of baseline homogeneity’ on prognostic covariates before proceeding to analyse the effects of treatment on outcome variables. It is argued that this practice is philosophically unsound, of no practical value and potentially misleading.
Featured Image
Why is it important?
Shows that you should use covariates rather than finding excuses for ignoring them.
Read the Original
This page is a summary of: Testing for baseline balance in clinical trials, Statistics in Medicine, September 1994, Wiley,
DOI: 10.1002/sim.4780131703.
You can read the full text:
Contributors
The following have contributed to this page